Baterna, Rowelyn G.
HRN: 08-99-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/03/2023
03/10/2023
IV
300mg
Q6h
Dental Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes